Seres Therapeutics, Inc. (MCRB) Financials

MCRB Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 117.6 million 91.1 million
Dec. 31, 2025 138.2 million 94.0 million
Sept. 30, 2025 143.5 million 99.8 million
June 30, 2025 143.8 million 110.9 million

MCRB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -16.4 million 1.8 million
Dec. 31, 2025 -14.7 million 3.2 million
Sept. 30, 2025 2.2 million 2.5 million
June 30, 2025 -13.5 million 2.3 million

MCRB Net Income

No data available :(

MCRB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 29.8 million - 69.6 million
Dec. 31, 2025 45.8 million - 72.6 million
Sept. 30, 2025 47.6 million - 75.3 million
June 30, 2025 45.4 million - 87.4 million

MCRB Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 9.6 million
Dec. 31, 2025 8.9 million
Sept. 30, 2025 8.8 million
June 30, 2025 8.7 million

MCRB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 13.2 million 8.1 million -
Dec. 31, 2025 29000 11.7 million 7.5 million -
Sept. 30, 2025 8000 12.6 million 9.5 million -
June 30, 2025 181000 12.9 million 10.3 million -

MCRB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 358000 781000
Dec. 31, 2025 438000 -13.8 million
Sept. 30, 2025 351000 13.4 million
June 30, 2025 - 1.1 million

MCRB Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MCRB

Price: $6.61

52 week price:
5.62
29.98

Earnings Per Share: -5.20 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 536116

Ebitda: -5.4 million

Market Capitalization: 69.7 million

Links: